Skip to search.
 TSX Up 0.11% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Incyte Corporation (INCY)

-NasdaqGS
46.99 Down 2.33(4.71%) 3:40PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:49.32
Open:49.32
Bid:46.73 x 200
Ask:46.81 x 800
1y Target Est:72.08
Beta:0.29
Next Earnings Date: 1-May-14INCY Earnings announcement
Day's Range:46.28 - 49.76
52wk Range:18.23 - 70.86
Volume:1,630,607
Avg Vol (3m):2,231,760
Market Cap:7.78B
P/E (ttm):N/A
EPS (ttm):-0.56
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Must Read

Comparison

Symbol% ChgMkt Cap
INCYDown 4.71%7.78B
AMGNDown 5.11%85.47B
CELGDown 1.14%58.86B
RHHBYUp 0.11%123.31B

Key Statistics

Forward P/E (1 yr):146.12
P/S (ttm):23.00
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.63
Quarterly EPS Est (Mar-14) :-0.17
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-0.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback